Pinnacle Financial Group, Inc.’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Other funds holding AKBA
Pinnacle Financial Group, Inc.'s AKBA Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Akebia Therapeutics (AKBA) in Q3 2026: 9,932 shares worth $9.14K. The stake represents ﹤0.01% of the portfolio and ranks #1626 among its holdings.
156 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.
- Pinnacle Financial Group, Inc. held 9,932 shares of Akebia Therapeutics worth $9.14K as of Q3 2026.
- Akebia Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Akebia Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1626 holding.
- 156 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.